Introduction
Neonates with hereditary spherocytosis (HS) can present with early and severe hemolytic jaundice and anemia, requiring intensive phototherapy and sometimes early erythrocyte transfusions. [1] [2] [3] [4] Because HS is the most common congenital hemolytic anemia of Caucasians, neonatologists often consider HS in the differential diagnosis of a patient with unexplained Coombs-negative hemolytic jaundice. Newborn infants with HS typically have spherocytes on blood smear and distinctive erythrocyte indices with an elevated mean corpuscular hemoglobin concentration (MCHC), generally >36 g dl À1 , and a low mean corpuscular volume (MCV) generally <90 fL. [2] [3] [4] Most neonates with HS, perhaps 70%, inherit the condition in an autosomal-dominant manner, with the remainder due to either a de novo mutation or rarely inherited as an autosomal-recessive disorder.
Neonates with Coombs-negative spherocytic hemolytic jaundice, where the mother or father are known to have HS, generally do not need confirmation of the diagnosis using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of erythrocyte membrane proteins. 2 However, we cared for a neonate with significant Coombs-negative hemolytic jaundice and anemia who had no family history of HS, but had spherocytes on blood smear yet normal red blood cell (RBC) indices. Erythrocyte membrane protein SDS-PAGE revealed an alpha-spectrin deficiency, indicating an autosomal-recessive variety comprising <5% of HS cases.
Case
This male was delivered vaginally at 38 weeks gestation after a normal pregnancy and labor to non-consanguineous Caucasian parents. No family members had anemia or jaundice. He weighed 3820 g, Apgar scores were 8 and 9 and he appeared healthy with no dysmorphic features. At 24 h, he was noted to be jaundiced with a total serum bilirubin of 15.2 mg dl À1 (13.9 unconjugated and 1.3 conjugated), and phototherapy was begun. Mother's and baby's blood types were both O ( þ ) and the direct antiglobulin test (Coombs) was negative. After 3 h, the total serum bilirubin was 13.8 mg dl À1 , hematocrit 34.1%, and three more phototherapy light units were added. At 72 h, the total serum bilirubin was 11.0 mg dl À1 , reticulocytes 13.6% and hematocrit 37%. At about 100 h, he was discharged home with a home-phototherapy unit and a total serum bilirubin of 14.1 mg dl À1 (13.7 unconjugated and 0.7 conjugated). He was bottle-feeding well and other than jaundice, he appeared healthy.
After 1 week, at the first outpatient visit to the pediatrician, he was reported to be feeding well and had regained birth weight but was obviously pale with a hemoglobin of 5.8 g dl
À1
. That morning he was taken to the Primary Children's Hospital Hematology Clinic for further evaluation and treatment. He was judged to be adequately hydrated and alert but had marked pallor and scleral/ cutaneous icterus. His heart rate was 170 per min and respiratory rate 38 per min. Laboratory values included hematocrit 18.8%, hemoglobin 6.3 g dl
, red cell distribution width 18.4, MCHC 33.5 g l À1 , MCH 31.8 pg, MCV 94.9 fL, reticulocyte count 8%, platelet count 357 000 per ml, mean platelet volume 11.0 fL and white blood cell 14 000 per ml with a normal leukocyte differential cell count but with 3.9 nucleated RBC per 100 white blood cell. Hemoglobin electrophoresis on the state metabolic screen was normal with only hemoglobins F and A reported. The blood film examination revealed many spherocytes, polychromasia, nucleated RBC and rare echinocytes. The RBCs were otherwise normochromic and normocytic, and the leukocytes and the platelets appeared normal in numbers and morphology. Pyruvate kinase activity was 17.3 U g À1 Hgb (normal 9.0 to 22.0) and G6PD activity was 12.9 U g À1 Hgb (normal 7.0 to 20.5). His father and mother had normal blood counts and normal cellular morphology on blood film examinations. Erythrocyte membrane protein analysis was performed on the neonate by SDS-PAGE with densitometric quantitation 5, 6 and showed normal proportions corresponding with ankyrin, band 3, protein 4.2 and b-spectrin, but deficient a-spectrin.
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During the next several months, RBC transfusions were administered almost monthly to keep his hemoglobin concentration X7.5 to 8.0 g dl À1 . Between age 12 months and 24 months his RBC transfusion rate was about 1 every 3 weeks. At 24 months, his height, weight and head circumference are all normal (70 to 85 percentile). He has no evidence of bilirubin neurotoxicity. Hearing and speech appear normal and he is meeting developmental milestones, but is notably pale prior to each transfusion and is generally mildly icteric.
Discussion
When evaluating a neonate with Coombs-negative hemolytic jaundice and a non-informative family history, the presence of spherocytes on blood film and a high MCHC and a low MCV suggest the diagnosis of HS. [1] [2] [3] [4] Indeed, among 34 children with HS followed in our clinic where we have CBCs during their neonatal period, 33 had an MCHC >36 g l À1 , whereas only this one patient had a normal MCHC (33.5 g l À1 ) (at term the 5th to 95th percentile reference range is 32.8 to 35.1 fL 8 ). Also, all of our other neonates with HS had a low MCV, generally <90 fL (the 5th to 95th % reference range is 100 to 110 fL at term 8 ), but in this patient, the MCV was normal. Besides the normal erythrocyte indices, this patient differs markedly in transfusion requirement from our other 33. The others have required at most six erythrocyte transfusions during their first 2 years,whereas this one received 26.
Spherocytes, obvious and abundant on our patient's blood film, are not diagnostic of HS. Spherocytes can occur in neonatal immune hemolytic anemia, particularly ABO hemolytic disease, in sepsis, microangiopathic hemolytic anemias and hemoglobin H disease. Osmotic fragility tests can be abnormal in all conditions where spherocytes are prominent, yet can be equivocal in neonates with HS. Therefore, osmotic fragility testing, like the appearance of spherocytes on blood film, is not entirely diagnostic of HS in a neonate.
Alpha-spectrin, deficient in our patient, is an integral part of the erythrocyte cytoskeleton, linked, along with b-spectrin, to the intracellular face of the plasma membrane through ankyrin and band 3 ( Table 1 ). The gene encoding alpha-spectrin (SPTA1) is located at 1q22-23. Alpha-spectrin is produced in developing erythrocytes in quantities exceeding, by three-to four-fold, the quantity of b-spectrin. These excess a-chains are degraded intracellularly. 2, 9 Individuals who are heterozygous for an a-spectrin deficiency will still produce a sufficient quantity of a-spectrin to balance the b-spectrin and therefore their erythrocytes are normal. Thus, the parents of our patient, obligate heterozygotes, have normal blood cell counts and morphology. However, neonates that are either homozygous for a SPTAI mutation or have compound heterozygous mutations in SPTAI are left with little or no erythrocyte a-spectrin, resulting in the rare and clinically severe autosomal-recessive form of HS we speculate in our patient. 14 Guideline recommendations suggest that SDS-PAGE analysis is not needed to confirm most cases of HS and that this should be reserved for selected atypical cases. 2 Our neonate was indeed The genes encoding these proteins, chromosomal locations of these genes, proportion of HS cases involving each protein, typical clinical severity of the condition and the typical pattern of inheritance are shown.
atypical in that, although spherocytes were prominent, the MCHC and MCV were normal. We speculate that in other neonates with Coombs-negative spherocytic hemolytic jaundice, if the erythrocyte indices are normal, SDS-PAGE analysis can indeed be worthwhile. Identifying the underlying cause of the erythrocyte disorder will facilitate genetic counseling and permit anticipatory guidance regarding the predicted severity of clinical phenotype.
